-like dopamine receptor partial agonist (EC50
= 57 nM). Vasodilator in vivo
and does not readily cross the blood-brain barrier. Also α2
-adrenoceptor antagonist in vitro
= 15 - 25 nM).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold for research purposes under agreement from GlaxoSmithKline
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
Hahn et al.
The pharmacology of fenoldopam.
Nichols et al.
Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.
Sibley et al.
Life Sci., 1982;31:637
The citations listed below are publications that use Tocris products. Selected citations for Fenoldopam hydrochloride include:
Showing Results 1 - 1 of 1